Inventor · disambiguated record
Manuel Zancanella
Also filed as: ZANCANELLA MANUEL
10 granted patents·5 pending applications·50 citations·filing 2008–2023
84Inventor score
Top patents by PatentIndex Score
15 records- 0197US9562061B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2015·Granted Feb 7, 2017·39 cites·30 claims
- 0291US10100063B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2016·Granted Oct 16, 2018·8 cites·12 claims
- 0381US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 0476US11111243B2Azaindole compounds as histone methyltransferase inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted Sep 7, 2021·1 cites·20 claims
- 0574US10836779B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted Nov 17, 2020·0 cites·8 claims
- 0671US11566030B2Substituted 2,6-dihydropyrrolo[3,4-c]pyrazoles as pyruvate kinase activatorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Granted Jan 31, 2023·0 cites·31 claims
- 0768US2023151016A1Pyrrolidine-pyrazoles as pyruvate kinase activatorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0863US2021371417A1Azaindole compounds as histone methyltransferase inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0962US2024140966A1Amorphous and crystalline forms of mcl-1 antagonistsAMGEN INC·Filed 2023·Application pending·0 cites
- 1058US8258321B2Beta-lactone compoundsSMITH JEFFREY W·Filed 2008·Granted Sep 4, 2012·0 cites·3 claims
- 1156US10144746B2Bridged bicyclic kallikrein inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·0 cites·17 claims
- 1254US2023159538A1Pyrrolidine-pyrazoles as pyruvate kinase activatorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1353US9815853B2Bridged bicyclic kallikrein inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2016·Granted Nov 14, 2017·0 cites·16 claims
- 1452US2023278984A1Urea derivatives as pyruvate kinase activatorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1544US11661410B2Tricyclic compounds as histone methyltransferase inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2018·Granted May 30, 2023·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Manuel Zancanella files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →